Apr 9 |
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
|
Apr 8 |
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Apr 1 |
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Apr 1 |
Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06
|
Mar 29 |
Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look
|
Mar 29 |
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
|
Mar 14 |
12 Most Profitable Biotech Stocks To Invest In
|
Mar 5 |
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Mar 5 |
Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week
|
Jan 8 |
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|